Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 08-Nov 2017. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 63323001000001115 | Salvacyl 11.25mg powder and solvent for suspension for injection vials (Ipsen Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 104996701000001111 | Salvacyl 11.25mg powder and solvent for suspension for injection vials (Ipsen) (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Salvacyl 11.25mg powder and solvent for suspension for injection vials (Ipsen) (product) | Is a | Triptorelin embonate 11.25mg powder and solvent for suspension for injection vials | false | Inferred relationship | Existential restriction modifier | ||
| Salvacyl 11.25mg powder and solvent for suspension for injection vials (Ipsen) (product) | Has active ingredient | Triptorelin | false | Inferred relationship | Existential restriction modifier | ||
| Salvacyl 11.25mg powder and solvent for suspension for injection vials (Ipsen) (product) | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Salvacyl 11.25mg powder and solvent for suspension for injection vials (Ipsen) (product) | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Salvacyl 11.25mg powder and solvent for suspension for injection vials (Ipsen) (product) | Has specific active ingredient | Triptorelin pamoate | false | Inferred relationship | Existential restriction modifier | ||
| Salvacyl 11.25mg powder and solvent for suspension for injection vials (Ipsen) (product) | Has dispensed dose form | Powder and solvent for suspension for injection | false | Inferred relationship | Existential restriction modifier | ||
| Salvacyl 11.25mg powder and solvent for suspension for injection vials (Ipsen) (product) | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Triptorelin | false | Inferred relationship | Existential restriction modifier | ||
| Salvacyl 11.25mg powder and solvent for suspension for injection vials (Ipsen) (product) | Has excipient | Polysorbate | false | Inferred relationship | Existential restriction modifier | ||
| Salvacyl 11.25mg powder and solvent for suspension for injection vials (Ipsen) (product) | Is a | Salvacyl | false | Inferred relationship | Existential restriction modifier | ||
| Salvacyl 11.25mg powder and solvent for suspension for injection vials (Ipsen) (product) | Is a | Actual medicinal product | false | Inferred relationship | Existential restriction modifier | ||
| Salvacyl 11.25mg powder and solvent for suspension for injection vials (Ipsen) (product) | Has manufactured dose form | Powder and solvent for suspension for injection | false | Inferred relationship | Existential restriction modifier | ||
| Salvacyl 11.25mg powder and solvent for suspension for injection vials (Ipsen) (product) | Has basis of strength substance | Triptorelin | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Salvacyl 11.25mg powder and solvent for suspension for injection vials (Ipsen) 1 vial (product) | Has AMP | False | Salvacyl 11.25mg powder and solvent for suspension for injection vials (Ipsen) (product) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR